Tonghua Dongbao Pharmaceutical Co., Ltd.

SHSE:600867 Stock Report

Market Cap: CN¥16.3b

Tonghua Dongbao Pharmaceutical Future Growth

Future criteria checks 5/6

Tonghua Dongbao Pharmaceutical is forecast to grow earnings and revenue by 54.3% and 23.6% per annum respectively. EPS is expected to grow by 53.5% per annum. Return on equity is forecast to be 15.8% in 3 years.

Key information

54.3%

Earnings growth rate

53.5%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate23.6%
Future return on equity15.8%
Analyst coverage

Good

Last updated03 Sep 2024

Recent future growth updates

Recent updates

Some May Be Optimistic About Tonghua Dongbao Pharmaceutical's (SHSE:600867) Earnings

Sep 06
Some May Be Optimistic About Tonghua Dongbao Pharmaceutical's (SHSE:600867) Earnings

Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Analysts Just Slashed This Year's Estimates

Sep 05
Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Analysts Just Slashed This Year's Estimates

Calculating The Intrinsic Value Of Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867)

Aug 22
Calculating The Intrinsic Value Of Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867)

Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Rock Solid Balance Sheet

Jun 19
Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Rock Solid Balance Sheet

Improved Earnings Required Before Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Shares Find Their Feet

May 23
Improved Earnings Required Before Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Shares Find Their Feet

Earnings and Revenue Growth Forecasts

SHSE:600867 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,1381,498N/A1,5626
12/31/20253,4141,218N/A1,3357
12/31/20242,104214N/A4552
6/30/20242,449453227667N/A
3/31/20243,0011,132524858N/A
12/31/20233,0751,168513862N/A
9/30/20232,771945130528N/A
6/30/20232,757884213611N/A
3/31/20232,5561,001213666N/A
12/31/20222,7781,582370863N/A
9/30/20222,9121,6435651,185N/A
6/30/20222,9931,8204051,160N/A
3/31/20223,3321,8034761,163N/A
12/31/20213,2681,3085801,180N/A
9/30/20213,1621,2426541,147N/A
6/30/20213,0791,0608491,188N/A
3/31/20212,9969898541,206N/A
12/31/20202,8929307131,192N/A
9/30/20202,9068796581,054N/A
6/30/20202,8178207941,174N/A
3/31/20202,7818158561,119N/A
12/31/20192,7778118591,152N/A
9/30/20192,7418397871,109N/A
6/30/20192,6648344771,001N/A
3/31/20192,6888381391,099N/A
12/31/20182,693839104877N/A
9/30/20182,701876263938N/A
6/30/20182,827963422954N/A
3/31/20182,699900N/A898N/A
12/31/20172,545837N/A961N/A
9/30/20172,414789N/A900N/A
6/30/20172,332736N/A818N/A
3/31/20172,154690N/A840N/A
12/31/20162,040641N/A726N/A
9/30/20161,909604N/A687N/A
6/30/20161,779546N/A577N/A
3/31/20161,722533N/A359N/A
12/31/20151,669493N/A295N/A
9/30/20151,661450N/A248N/A
6/30/20151,576393N/A105N/A
3/31/20151,521321N/A158N/A
12/31/20141,451280N/A206N/A
9/30/20141,369215N/A142N/A
6/30/20141,308216N/A285N/A
3/31/20141,265198N/A305N/A
12/31/20131,204184N/A221N/A
9/30/20131,141119N/A290N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600867's forecast earnings growth (54.3% per year) is above the savings rate (2.9%).

Earnings vs Market: 600867's earnings (54.3% per year) are forecast to grow faster than the CN market (23% per year).

High Growth Earnings: 600867's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600867's revenue (23.6% per year) is forecast to grow faster than the CN market (13.1% per year).

High Growth Revenue: 600867's revenue (23.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600867's Return on Equity is forecast to be low in 3 years time (15.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y